Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta‐analysis of randomized controlled trials.

MLA

Akobeng, Anthony K., et al. “Patent Foramen Ovale (PFO) Closure versus Medical Therapy for Prevention of Recurrent Stroke in Patients with Prior Cryptogenic Stroke: A Systematic Review and Meta‐analysis of Randomized Controlled Trials.” Catheterization & Cardiovascular Interventions, vol. 92, no. 1, July 2018, pp. 165–73. EBSCOhost, https://doi.org/10.1002/ccd.27615.

APA

Akobeng, A. K., Abdelgadir, I., Boudjemline, Y., & Hijazi, Z. M. (2018). Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta‐analysis of randomized controlled trials. Catheterization & Cardiovascular Interventions, 92(1), 165–173. https://doi.org/10.1002/ccd.27615

Chicago

Akobeng, Anthony K., Ibtihal Abdelgadir, Younes Boudjemline, and Ziyad M. Hijazi. 2018. “Patent Foramen Ovale (PFO) Closure versus Medical Therapy for Prevention of Recurrent Stroke in Patients with Prior Cryptogenic Stroke: A Systematic Review and Meta‐analysis of Randomized Controlled Trials.” Catheterization & Cardiovascular Interventions 92 (1): 165–73. doi:10.1002/ccd.27615.